SAM:
Posted on January 24, 2016 by Noah Nemoy As a valued MEMOTEXT client we’d like to give you a sneak peek at our latest technological advancement: SAM! SAM is the MEMOTEXT ChatBot for
24 January 2016
Media
From the MedX Mainstage to the TSX (Toronto Stock Exchange)
Looking back on MEMOTEXT’s accomplishments this fall
Posted on December 2, 2015 by Noah Nemoy
This autumn has been an exciting time for MEMOTEXT. In September our Founder and President Amos Adler had the opportunity to be a main stage speaker at Stanford Medicine X 2015. Presenting the abstract: “Using Disparate Data to Personalize Digital Health Behavior Change Interventions” Amos rocked the crowd explaining the MEMOTEXT methodology. He had a fantastic time at the event and the “Cat pics + health data = behavior change” line got a substantial amount of press coverage.
1 December 2015
Click Bait for Your Health: How a Toronto Startup Uses Digital Engagement to Increase Medication Adherence
Posted on November 20, 2015 by Amos Adler
Using digital engagement to increase medication adherence is our novel solution to a complex problem. With non-adherence caused by multiple factors unique to each individual patient, a-one-size-fits-all-solution can’t work and won’t work. Instead, at MEMOTEXT we personalize each patient’s support program. By encouraging patient input, adapting to changes in mood and lifestyle, we can develop a medication adherence and support program that works best.
25 November 2015
If I had $290 billion: Breaking Down the Cost of Medication Compliance
Posted on November 05, 2015 by Noah Nemoy
Medication Compliance is one of the biggest costs to worldwide healthcare systems. 50% of all patients do not take their medication as prescribed and this costs the U.S. healthcare system alone $290 billion per year. That’s a pretty massive figure that can be interpreted in several ways.
We can start by breaking down that $290 billion to show exactly how low compliance rates create such a huge cost:
5 November 2015
EmpathyX – My MedXHangover Elixer
Posted on October 02, 2015 by Amos Adler
Keywords: #MedXHangover #EmpathyX #MedXorcism, #ActionX
So I’m currently suffering from what’s known as #MedXHangover. Its real, I assure you. Fortunately I don’t have #SyndromeX, a condition associated with attending uncomfortable doctor-patient simulations to simulate uncomfortable doctor-patient interactions.
1 October 2015
MEMOTEXT Goes to the Canadian Psychiatric Association (CPA) Annual meeting in Vancouver, BC.
Posted on September 30, 2015 by Bill Simpson
As the Director of Scientific Development for MEMOTEXT I am honoured to have been invited to speak at this year’s Canadian Psychiatric Association (CPA) annual conference. The 2015 conference runs from Annual Conference October 1st – 3rd in Vancouver, British Columbia. I will be speaking at the “A clinician’s guide to mental health apps.” symposium on Thursday, October 1st at 10:15 PST. The focus of my contribution will be on mHealth and its capacity to affect positive behavioural change.
30 September 2015
MEMOTEXT Founder and President Amos Adler to Present at Stanford Medicine X 2015
Abstract: “Using Disparate Data to Personalize Digital Health Behavior Change Interventions” to be presented at conference main stage
Toronto, ON September 16, 2015 – MEMOTEXT is pleased to announce that our Founder and President Amos Adler will be a main stage speaker at Stanford Medicine X 2015. Running from September 23-27 in the heart of Silicon Valley, Medicine X is a catalyst for sharing new ideas on the intersection of healthcare and emerging technologies. Hosted by Stanford University, Medicine X brings together both business and academia for a 4 day conversation on the future of healthcare.
16 September 2015
The Meaning of “Meaningful Use”
How MEMOTEXT helps you achieve it
Posted on October 13, 2015 by Noah Nemoy
If you’re an American health care provider or are involved in digital health, odds are you’ve been hearing a lot about Meaningful Use (MU) Stage 3 in recent years. But what is it exactly? Why does it matter? And while we’re at it, what is MU Stages 1 and 2?
1 September 2015
MEMOTEXT Publishes Whitepaper on Patient Adherence & Digital Health Interventions
“The MEMOTEXT Toolkit” walks readers through the problem of patient non-adherence, explaining the methodology behind our digital health interventions
Posted on July 23, 2015 by Noah Nemoy
MEMOTEXT is pleased to unveil “The MEMOTEXT Toolkit” Whitepaper. Authored by MEMOTEXT’s President and Founder Amos Adler M.Sc., Director of Scientific Development Bill Simpson P.hD(c) and Miki Peer P.hD(c), the document explains both the problem of patient adherence and outlines the science behind MEMOTEXT’s methodology.
22 July 2015
We’re Going to Stanford!
MEMOTEXT Founder and President Amos Adler to Present at Stanford Medicine X 2015
Posted on July 23, 2015 by Noah Nemoy
MEMOTEXT is pleased to announce that our President and Founder Amos Adler will be speaking at Stanford Medicine X 2015! Running from September 23-27 in the heart of Silicon Valley, Medicine X is a catalyst for sharing new ideas on the intersection of healthcare and emerging technologies. Hosted by Stanford University, Medicine X brings together both business and academia for a 4 day conversation on the future of healthcare.
22 July 2015
MEMOTEXT Makes the Top 20
MEMOTEXT is named by HIT Consultant as one of the Top 20 Canadian Digital Health Technology Start-Ups to Watch
Posted on July 23, 2015 by Noah Nemoy
Earlier this month HIT Consultant, released their list of the Top 20 Canadian digital health companies to lookout for. The companies on the list were selected for their potential for growth and represented disparate areas of digital health, including digital health solutions, diagnostics, and patient centred care. MEMOTEXT managed to not only make the Top 20, but was also one of the Top 10 digital health start-ups in Eastern Canada, and the only company of the 20 with an exclusive focus on patient adherence.
22 July 2015
MEMOTEXT Pitches PAAS2015
Posted on July 6, 2015 by Noah Nemoy
Last week, MEMOTEXT Founder and President Amos Adler was invited to both attend and present at the 14th Annual Patient Adherence & Access Summit, or PAAS2015 in Philadelphia. While there MEMOTEXT had the opportunity to share in the discussion of the latest issues regarding patient adherence and access, to medication.
6 July 2015